Vir Biotechnology (VIR) Shares Outstanding (2018 - 2026)

Vir Biotechnology's Shares Outstanding history runs 9 years deep, the most recent figure standing at $161.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 16.78% year-over-year to $161.2 million; the TTM figure through Mar 2026 stood at $161.2 million (up 16.78% YoY), while the FY2025 annual figure was $139.5 million, up 1.84% from the prior year.
• Shares Outstanding came in at $161.2 million for Q1 2026 at Vir Biotechnology, up from $139.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $161.2 million in Q1 2026 to a low of $132.4 million in Q1 2022.
• A 5-year average of $137.1 million and a median of $135.8 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding gained 1.11% in 2023 and increased 16.78% in 2026, its largest moves.
• Vir Biotechnology's Shares Outstanding stood at $133.2 million in 2022, then rose by 1.16% to $134.8 million in 2023, then increased by 1.62% to $137.0 million in 2024, then increased by 1.84% to $139.5 million in 2025, then increased by 15.6% to $161.2 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $161.2 million, $139.5 million, and $139.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison